Le Lézard
Classified in: Ebola virus, Health, Business
Subjects: ERN, ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2022


GOTHENBURG, Sweden, Sept. 5, 2022 /PRNewswire/ -- Zinzino group revenue increased with a total of 16%, compared with the previous year.

The revenue in August for Zinzino's sales markets increased by 14% and amounted to SEK 103.5 (90.9) million. Faun Pharma's external sales increased by 52% and amounted to SEK 7.3 (4.8) million. Overall, the Group increased revenues by 16% to SEK 110.8 (95.7) million compared with the previous year.

Accumulated revenue for January ? August 2022 increased by 4% to SEK 884.2 (850.9) million.

Revenues were distributed as follows:

Regions, mSEK

22-Aug

21-Aug

Change

YTD 2022

YTD 2021

Change 

The Nordics

24.2

27.3

-11 %

206.7

242.5

-15 %

Central Europe

23.0

17.1

35 %

168.8

142.8

18 %

East Europe

25.0

24.4

2 %

209.3

209.8

0 %

South & West Europe

11.9

9.9

20 %

98.8

91.2

8 %

The Baltics

5.3

5.1

4 %

45.8

46.2

-1 %

North America

6.4

3.0

113 %

45.5

32.1

42 %

Asia-Pacific

6.9

4.1

68 %

49.5

45.3

9 %

Africa

0.8

0.0


4.9

0.0


Zinzino

103.5

90.9

14 %

829.3

809.9

2 %

Faun Pharma

7.3

4.8

52 %

54.9

41.0

34 %

Zinzino Group

110.8

95.7

16 %

884.2

850.9

4 %

 

Countries in regions:

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 14:00 the 5th of September 2022.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-august-2022,c3625960

The following files are available for download:

https://mb.cision.com/Main/10976/3625960/1623204.pdf

2208 Pressrelease Salesreport EN


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 10:12
AnX Robotica, the leader in advanced gastrointestinal visualization technologies, is happy to announce the appointment of two industry veterans to the leadership team....



News published on and distributed by: